Growing demand among travelers the Global Travel Vaccines Market to grow at a CAGR of 6.83% Over 2016-2020

As the world continues to move toward globalization, the international travels will keep increasing. This fuels the demand for travel vaccines as the prevalence of infectious diseases are specifically region prone, unlike that of other indications. As vaccines are largely used as a preventive measure against these known infectious diseases, the travelers are advised to follow the region-specific immunization plan. The market is growing because various government bodies have mandated the immunization of travelers visiting the infectious-prone areas with various types of vaccines. This, in turn, prevents the spread of infection and averts any chances of epidemic outbreaks.

Technavios analysts forecast the global travel vaccines market to grow at a CAGR of 6.83% during the period 2016-2020.

Download Sample Copy Of This Report : http://www.marketresearchreports.biz/sample/sample/883460

Covered in this report
The report covers the present scenario and the growth prospects of the global travel vaccines market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of various vaccines administered to actively immunize meningococcal disease, Japanese encephalitis, rabies, typhoid, yellow fever, hepatitis B, and hepatitis A. The report also considers the revenues to be generated from the sales of vaccines that are expected to be launched into the market during the forecast period.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Travel Vaccines Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
GlaxoSmithKline
Merck
Pfizer
Sanofi

View Full Report : http://www.marketresearchreports.biz/analysis/883460

Other prominent vendors
Abbott
AstraZeneca
Bavarian Nordic
Baxter
Beijing Minhai Biotechnology
Bharat Biotech
Bharat Immunologicals and Biologicals
Bio-Med
Seqirus CSL
Crucell
CSL
Dynavax Technologies
Emergent BioSolutions
GlycoVaxyn
GreenSignal Bio Pharma
Hualan Biological Engineering
Imunoloski Zavod
Indian Immunologicals
Janssen Pharmaceuticals
JN International Medical
Kaketsuken
LG Life Sciences
Lupin
Mitsubishi Tanabe Pharma
Novavax
Nuron Biotech
Panacea Biotec
Pfizer
Protein Sciences
Roche
SK Chemicals
Serum Institute of India
Shenzhen Kangtai Biological Products
Sinovac Biotech
Takeda Pharmaceutical
Vacunas Finlay
Valeant Pharmaceuticals
Valneva,
Zydus Cadila

Market driver
Growing demand among travelers
For a full, detailed list, view our report

Market challenge
Requires specific storage and distribution system
For a full, detailed list, view our report

Market trend
Combination vaccines
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.

MarketResearchReports.biz supports your business intelligence needs with over 100,000 market research reports, company profiles, data books, and regional market data sheets in its repository. Our document database is updated by the hour, which means that you always have access to fresh data spanning over 300 industries and their sub-segments.

State Tower
90 State Street, Suite 700
Albany, NY 12207
United States

Toll Free: 866-997-4948
(USA-CANADA)

Tel: +1-518-621-2074
E: sales@marketresearchreports.biz

This release was published on openPR.